Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for infantile spasms: randomized double-blind placebo-controlled trial following open-label pilot
2015-004904-50Phase 3Completed
- Sponsor
- GW Pharmaceuticals
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol in West syndrome (3 arms), sponsored by GW Pharmaceuticals. Started Apr 2017; status: completed.
02
Drugs
cannabidiol
03
Conditions
West syndrome
Beyond the preview
Go deeper on 2015-004904-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004904-50.